A retrospective, observational study of cardiovascular toxicity in cancer patients treated with tyrosine kinase inhibitors
Latest Information Update: 29 Jul 2020
At a glance
- Drugs Dasatinib (Primary) ; Imatinib (Primary) ; Nilotinib (Primary) ; Ponatinib (Primary)
- Indications Cardiovascular disorders; Chronic myeloid leukaemia; Gastrointestinal stromal tumours
- Focus Adverse reactions
- 29 Jul 2020 New trial record